Study Information

Title: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy External
Status: Recruiting participants
Conditions: Head and Neck Cancer
Interventions: Drug: bortezomib
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital
Health Topics: Head and Neck Cancer

Contact Information


Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Boston, MA 02115
Marshall R. Posner, MD
617-632-3090
marshall_posner@dfci.harvard.edu
Massachusetts General Hospital
Boston, MA 02114
Clinical Trials Office - Massachusetts General Hospital
877-726-5130